vTv Therapeutics (VTVT) Minority Interest (2014 - 2025)

vTv Therapeutics has disclosed Minority Interest across 12 years of filings, most recently posting -$357000.0 for Q2 2025.

• Minority Interest for Q2 2025 came in at -$357000.0, down 109.01% year-over-year; the trailing twelve-month figure through Jun 2025 was -$357000.0 (down 109.01% YoY), and the FY2024 annual result was $2.1 million, changed N/A from the prior year.
• Minority Interest came in at -$357000.0 for Q2 2025 at vTv Therapeutics, down from $977000.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $62.6 million in Q1 2021 to a low of -$357000.0 in Q2 2025.
• The 5-year median for Minority Interest is $16.2 million (2022), against an average of $20.3 million.
• Across the five-year window, Minority Interest surged 36.42% in 2023 and plunged 109.01% in 2025, its largest moves.
• vTv Therapeutics' Minority Interest stood at $25.0 million in 2021, then tumbled by 33.58% to $16.6 million in 2022, then tumbled by 35.33% to $10.7 million in 2023, then tumbled by 80.4% to $2.1 million in 2024, then tumbled by 116.98% to -$357000.0 in 2025.
• The last three Minority Interest figures came in at -$357000.0 (Q2 2025), $977000.0 (Q1 2025), and $2.1 million (Q4 2024), per Business Quant data.